EVM
IDNA icon

Eaton Vance Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Eaton Vance Management’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25
Closed – – 2846
2021
Q3 		$0 Hold
25
– – ﹤0.01% 2332
2021
Q2 		$1K Buy
+25
New +$1.17K ﹤0.01% 2762

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Eaton Vance Management's IDNA Position: Q4 2021 in Review

Eaton Vance Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2021, closing a stake of 25 shares.

Eaton Vance Management first reported a position in IDNA in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 103 funds tracked by Wall St. Rank hold IDNA as of Q4 2021.

  • Eaton Vance Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2021 after selling out during the quarter.
  • Eaton Vance Management sold 25 iShares Genomics Immunology and Healthcare ETF shares in Q4 2021.
  • Eaton Vance Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2021 and held it in 2 quarters.
  • Eaton Vance Management's iShares Genomics Immunology and Healthcare ETF position peaked at $1K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2021.

Based on Eaton Vance Management's 13F filing for Q4 2021, filed 14 Feb 2022.